For the three months ended October 3, 2026, Waters reported total net revenues of 1,767 million, up from 800 million. Operating income fell to 128 million from 192 million, and net income declined to 81 million from 149 million.
WAT · Waters Corp
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Waters Corporation reported third quarter of 2026 revenue of $1.767 billion and adjusted EPS of $4.10, up 21%, while raising full-year 2026 guidance.
Waters Corp reported 2Q organic growth of 9% and reached a 200 million cost-synergy run rate within nine months, versus its original three-year target. Management expects the acquired businesses to accelerate and significant margin expansion in 2027.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Acquired Business Contribution non-GAAP | 1.34B | Six Months Ended July 4, 2026 | — |
| ASD Instrument Revenue | 240M | Three Months Ended July 4, 2026 | — |
| Constant Currency ASD Instrument Revenue Growth non-GAAP | 8% | Three Months Ended July 4, 2026 | — |
| Free Cash Flow - Adjusted Non-GAAP non-GAAP | $161M | Six Months Ended July 4, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net cash provided by operating activities - GAAP 200M
-49M Additions to property, plant, equipment, and software capitalization
+0M Tax reform payments
+0M Litigation settlements received, net
+0M Payment of Wyatt retention bonus obligation
+51M Change in deposit asset
= Free Cash Flow - Adjusted Non-GAAP 202M
|
|||
| Organic Constant Currency Revenue Growth non-GAAP | 10% | Six Months Ended July 4, 2026 | — |
| Organic Reported Revenue Growth non-GAAP | 10% | Six Months Ended July 4, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WAT
this stock
Waters Corp
|
$44.56B | +19.4% | +7.0% | — | 3.4% |
|
TMO
Thermo Fisher Scientific Inc.
|
$256.15B | +19.3% | +14.5% | 36.5 | 1.3% |
|
DHR
Danaher Corp
|
$161.75B | +0.4% | +8.5% | 37.6 | 1.2% |
|
IDXX
Idexx Laboratories Inc
|
$55.20B | +3.6% | +10.4% | 47.2 | 3.0% |
|
A
Agilent Technologies, Inc.
|
$48.75B | +27.1% | +6.4% | 34.0 | 1.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 10, 2026
- This year
- 21
For the three months ended October 3, 2026, Waters reported total net revenues of 1,767 million, up from 800 million. Operating income fell to 128 million from 192 million, and net income declined to 81 million from 149 million.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WAT | -4.9% | +4.4% | +32.5% | -2.0% | +19.4% |
| SPY | -1.7% | -3.5% | -1.4% | -2.1% | +8.5% |
| vs SPY | -3.2% | +7.9% | +33.9% | +0.1% | +10.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.